The Physicians' Health Study is a randomized, double-blind, placebo-controlled trial designed to determine whether low-dose aspirin (325 mg every other day) decreases cardiovascular mortality and whether beta carotene reduces the incidence of cancer. The aspirin component was terminated earlier than scheduled, and the preliminary findings were published. We now present detailed analyses of the cardiovascular component for 22,071 participants, at an average follow-up time of 60.2 months. There was a 44 percent reduction in the risk of myocardial infarction (relative risk, 0.56; 95 percent confidence interval, 0.45 to 0.70; P less than 0.00001) in the aspirin group (254.8 per 100,000 per year as compared with 439.7 in the placebo group). A slightly increased risk of stroke among those taking aspirin was not statistically significant; this trend was observed primarily in the subgroup with hemorrhagic stroke (relative risk, 2.14; 95 percent confidence interval, 0.96 to 4.77; P = 0.06). No reduction in mortality from all cardiovascular causes was associated with aspirin (relative risk, 0.96; 95 percent confidence interval, 0.60 to 1.54). Further analyses showed that the reduction in the risk of myocardial infarction was apparent only among those who were 50 years of age and older. The benefit was present at all levels of cholesterol, but appeared greatest at low levels. The relative risk of ulcer in the aspirin group was 1.22 (169 in the aspirin group as compared with 138 in the placebo group; 95 percent confidence interval, 0.98 to 1.53; P = 0.08), and the relative risk of requiring a blood transfusion was 1.71. This trial of aspirin for the primary prevention of cardiovascular disease demonstrates a conclusive reduction in the risk of myocardial infarction, but the evidence concerning stroke and total cardiovascular deaths remains inconclusive because of the inadequate numbers of physicians with these end points.
This article has been cited by other articles:
Britton, K. A., Gaziano, J. M., Djousse, L.
(2009). Normal systolic blood pressure and risk of heart failure in US male physicians. Eur J Heart Fail
11: 1129-1134
[Abstract][Full Text]
Calvin, A. D., Aggarwal, N. R., Murad, M. H., Shi, Q., Elamin, M. B., Geske, J. B., Fernandez-Balsells, M. M., Albuquerque, F. N., Lampropulos, J. F., Erwin, P. J., Smith, S. A., Montori, V. M.
(2009). Aspirin for the Primary Prevention of Cardiovascular Events: A systematic review and meta-analysis comparing patients with and without diabetes. Diabetes Care
32: 2300-2306
[Abstract][Full Text]
De Berardis, G., Sacco, M., Strippoli, G. F M, Pellegrini, F., Graziano, G., Tognoni, G., Nicolucci, A.
(2009). Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials. BMJ
339: b4531-b4531
[Abstract][Full Text]
(2009). Aspirin for primary prevention of cardiovascular disease?. DTB
47: 122-125
[Abstract][Full Text]
Ridker, P. M, MacFadyen, J. G., Fonseca, F. A.H., Genest, J., Gotto, A. M., Kastelein, J. J.P., Koenig, W., Libby, P., Lorenzatti, A. J., Nordestgaard, B. G., Shepherd, J., Willerson, J. T., Glynn, R. J., for the JUPITER Study Group,
(2009). Number Needed to Treat With Rosuvastatin to Prevent First Cardiovascular Events and Death Among Men and Women With Low Low-Density Lipoprotein Cholesterol and Elevated High-Sensitivity C-Reactive Protein: Justification for the Use of statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER). Circ Cardiovasc Qual Outcomes
2: 616-623
[Abstract][Full Text]
Stark, J. R., Judson, G., Alderete, J. F., Mundodi, V., Kucknoor, A. S., Giovannucci, E. L., Platz, E. A., Sutcliffe, S., Fall, K., Kurth, T., Ma, J., Stampfer, M. J., Mucci, L. A.
(2009). Prospective Study of Trichomonas vaginalis Infection and Prostate Cancer Incidence and Mortality: Physicians' Health Study. JNCI J Natl Cancer Inst
101: 1406-1411
[Abstract][Full Text]
Djousse, L., Driver, J. A., Gaziano, J. M.
(2009). Relation Between Modifiable Lifestyle Factors and Lifetime Risk of Heart Failure. JAMA
302: 394-400
[Abstract][Full Text]
Stark, J. R., Perner, S., Stampfer, M. J., Sinnott, J. A., Finn, S., Eisenstein, A. S., Ma, J., Fiorentino, M., Kurth, T., Loda, M., Giovannucci, E. L., Rubin, M. A., Mucci, L. A.
(2009). Gleason Score and Lethal Prostate Cancer: Does 3 + 4 = 4 + 3?. JCO
27: 3459-3464
[Abstract][Full Text]
O'Kane, P., Xie, L., Liu, Z., Queen, L., Jackson, G., Ji, Y., Ferro, A.
(2009). Aspirin acetylates nitric oxide synthase type 3 in platelets thereby increasing its activity. Cardiovasc Res
83: 123-130
[Abstract][Full Text]
Schaumberg, D. A., Dana, R., Buring, J. E., Sullivan, D. A.
(2009). Prevalence of Dry Eye Disease Among US Men: Estimates From the Physicians' Health Studies. Arch Ophthalmol
127: 763-768
[Abstract][Full Text]
Pulcinelli, F. M., Biasucci, L. M., Riondino, S., Giubilato, S., Leo, A., Di Renzo, L., Trifiro, E., Mattiello, T., Pitocco, D., Liuzzo, G., Ghirlanda, G., Crea, F.
(2009). COX-1 sensitivity and thromboxane A2 production in type 1 and type 2 diabetic patients under chronic aspirin treatment. Eur Heart J
30: 1279-1286
[Abstract][Full Text]
Penney, K. L., Salinas, C. A., Pomerantz, M., Schumacher, F. R., Beckwith, C. A., Lee, G.-S., Oh, W. K., Sartor, O., Ostrander, E. A., Kurth, T., Ma, J., Mucci, L., Stanford, J. L., Kantoff, P. W., Hunter, D. J., Stampfer, M. J., Freedman, M. L.
(2009). Evaluation of 8q24 and 17q Risk Loci and Prostate Cancer Mortality. Clin. Cancer Res.
15: 3223-3230
[Abstract][Full Text]
Angiolillo, D. J.
(2009). Antiplatelet Therapy in Diabetes: Efficacy and Limitations of Current Treatment Strategies and Future Directions. Diabetes Care
32: 531-540
[Full Text]
Nuzum, D. S., Merz, T.
(2009). Macrovascular Complications of Diabetes Mellitus. Journal of Pharmacy Practice
22: 135-148
[Abstract]
Lee, J. E., Li, H., Giovannucci, E., Lee, I-M., Selhub, J., Stampfer, M., Ma, J.
(2009). Prospective Study of Plasma Vitamin B6 and Risk of Colorectal Cancer in Men. Cancer Epidemiol. Biomarkers Prev.
18: 1197-1202
[Abstract][Full Text]
Petrea, R. E., Beiser, A. S., Seshadri, S., Kelly-Hayes, M., Kase, C. S., Wolf, P. A.
(2009). Gender Differences in Stroke Incidence and Poststroke Disability in the Framingham Heart Study. Stroke
40: 1032-1037
[Abstract][Full Text]
Konstam, M. A.
(2009). Antithrombotic Therapy in Heart Failure: WATCHful Wondering. Circulation
119: 1559-1561
[Full Text]
Wolff, T., Miller, T., Ko, S.
(2009). Aspirin for the Primary Prevention of Cardiovascular Events: An Update of the Evidence for the U.S. Preventive Services Task Force. ANN INTERN MED
150: 405-410
[Abstract][Full Text]
Pignone, M.
(2009). Aspirin for Cardiovascular Prevention in Patients With Diabetes. Clin. Diabetes
27: 70-71
[Full Text]
Wang, X., Cheng, S., Brophy, V. H., Erlich, H. A., Mannhalter, C., Berger, K., Lalouschek, W., Browner, W. S., Shi, Y., Ringelstein, E. B., Kessler, C., Luedemann, J., Lindpaintner, K., Liu, L., Ridker, P. M., Zee, R. Y.L., Cook, N. R., for the RMS Stroke SNP Consortium,
(2009). A Meta-Analysis of Candidate Gene Polymorphisms and Ischemic Stroke in 6 Study Populations: Association of Lymphotoxin-Alpha in Nonhypertensive Patients. Stroke
40: 683-695
[Abstract][Full Text]
Gorelick, P. B.
(2009). Challenges of Designing Trials for the Primary Prevention of Stroke. Stroke
40: S82-S84
[Abstract][Full Text]
Driver, J. A., Logroscino, G., Gaziano, J. M., Kurth, T.
(2009). Incidence and remaining lifetime risk of Parkinson disease in advanced age. Neurology
72: 432-438
[Abstract][Full Text]
Dhillon, P. K., Barry, M., Stampfer, M. J., Perner, S., Fiorentino, M., Fornari, A., Ma, J., Fleet, J., Kurth, T., Rubin, M. A., Mucci, L. A.
(2009). Aberrant Cytoplasmic Expression of p63 and Prostate Cancer Mortality. Cancer Epidemiol. Biomarkers Prev.
18: 595-600
[Abstract][Full Text]
Djousse, L., Gaziano, J. M., Buring, J. E., Lee, I-M.
(2009). Egg Consumption and Risk of Type 2 Diabetes in Men and Women. Diabetes Care
32: 295-300
[Abstract][Full Text]
Gaziano, J. M., Glynn, R. J., Christen, W. G., Kurth, T., Belanger, C., MacFadyen, J., Bubes, V., Manson, J. E., Sesso, H. D., Buring, J. E.
(2009). Vitamins E and C in the Prevention of Prostate and Total Cancer in Men: The Physicians' Health Study II Randomized Controlled Trial. JAMA
301: 52-62
[Abstract][Full Text]
Kenchaiah, S., Sesso, H. D., Gaziano, J. M.
(2009). Body Mass Index and Vigorous Physical Activity and the Risk of Heart Failure Among Men. Circulation
119: 44-52
[Abstract][Full Text]
Driver, J. A, Djousse, L., Logroscino, G., Gaziano, J M., Kurth, T.
(2008). Incidence of cardiovascular disease and cancer in advanced age: prospective cohort study. BMJ
337: a2467-a2467
[Abstract][Full Text]
Cleland, J. G F
(2008). Time for a proper study of aspirin after a vascular event?. BMJ
337: a2583-a2583
[Full Text]
Sesso, H. D., Buring, J. E., Christen, W. G., Kurth, T., Belanger, C., MacFadyen, J., Bubes, V., Manson, J. E., Glynn, R. J., Gaziano, J. M.
(2008). Vitamins E and C in the Prevention of Cardiovascular Disease in Men: The Physicians' Health Study II Randomized Controlled Trial. JAMA
300: 2123-2133
[Abstract][Full Text]
Ogawa, H., Nakayama, M., Morimoto, T., Uemura, S., Kanauchi, M., Doi, N., Jinnouchi, H., Sugiyama, S., Saito, Y., for the Japanese Primary Prevention of Atheroscler,
(2008). Low-Dose Aspirin for Primary Prevention of Atherosclerotic Events in Patients With Type 2 Diabetes: A Randomized Controlled Trial. JAMA
300: 2134-2141
[Abstract][Full Text]
Chavarro, J. E, Stampfer, M. J, Hall, M. N, Sesso, H. D, Ma, J.
(2008). A 22-y prospective study of fish intake in relation to prostate cancer incidence and mortality. Am. J. Clin. Nutr.
88: 1297-1303
[Abstract][Full Text]
Bulugahapitiya, U, Siyambalapitiya, S, Sithole, J, Fernando, D J, Idris, I
(2008). Age threshold for vascular prophylaxis by aspirin in patients without diabetes. Heart
94: 1429-1432
[Abstract][Full Text]
Walsh, M., Spurling, G.
(2008). Aspirin in type 2 diabetes: is there any evidence base?. BMJ
337: a1902-a1902
[Full Text]
Hiatt, W. R
(2008). Aspirin for prevention of cardiovascular events. BMJ
337: a1806-a1806
[Full Text]
Djousse, L., Rudich, T., Gaziano, J M.
(2008). Nut consumption and risk of heart failure in the Physicians' Health Study I. Am. J. Clin. Nutr.
88: 930-933
[Abstract][Full Text]
Driver, J. A., Smith, A., Buring, J. E., Gaziano, J. M., Kurth, T., Logroscino, G.
(2008). Prospective Cohort Study of Type 2 Diabetes and the Risk of Parkinson's Disease. Diabetes Care
31: 2003-2005
[Abstract][Full Text]
Gelber, R. P., Gaziano, J. M., Orav, E. J., Manson, J. E., Buring, J. E., Kurth, T.
(2008). Measures of Obesity and Cardiovascular Risk Among Men and Women. J Am Coll Cardiol
52: 605-615
[Abstract][Full Text]
Litwin, S. E.
(2008). Which Measures of Obesity Best Predict Cardiovascular Risk?. J Am Coll Cardiol
52: 616-619
[Full Text]
Zaman Huri, H., Lee Qiu Yi, , Pendek, R., Che Zuraini Sulaiman,
(2008). Use of Antiplatelet Agents for Primary and Secondary Prevention of Cardiovascular Disease Amongst Type 2 Diabetic Patients. Journal of Pharmacy Practice
21: 287-301
[Abstract]
Triplitt, C., Alvarez, C. A.
(2008). Best Practices for Lowering the Risk of Cardiovascular Disease in Diabetes. Diabetes Spectr.
21: 177-189
[Abstract][Full Text]
Norris, S. L., Kansagara, D., Bougatsos, C., Fu, R.
(2008). Screening Adults for Type 2 Diabetes: A Review of the Evidence for the U.S. Preventive Services Task Force. ANN INTERN MED
148: 855-868
[Abstract][Full Text]
Mosca, L.
(2008). Aspirin Chemoprevention: One Size Does Not Fit All. Circulation
117: 2844-2846
[Full Text]
Patrono, C., Baigent, C., Hirsh, J., Roth, G.
(2008). Antiplatelet Drugs: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest
133: 199S-233S
[Abstract][Full Text]
Becker, R. C., Meade, T. W., Berger, P. B., Ezekowitz, M., O'Connor, C. M., Vorchheimer, D. A., Guyatt, G. H., Mark, D. B., Harrington, R. A.
(2008). The Primary and Secondary Prevention of Coronary Artery Disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest
133: 776S-814S
[Abstract][Full Text]
Hall, M. N., Chavarro, J. E., Lee, I-M., Willett, W. C., Ma, J.
(2008). A 22-year Prospective Study of Fish, n-3 Fatty Acid Intake, and Colorectal Cancer Risk in Men. Cancer Epidemiol. Biomarkers Prev.
17: 1136-1143
[Abstract][Full Text]
Driver, J. A., Kurth, T., Buring, J. E., Gaziano, J. M., Logroscino, G.
(2008). Parkinson disease and risk of mortality: A prospective comorbidity-matched cohort study. Neurology
70: 1423-1430
[Abstract][Full Text]
Djousse, L., Gaziano, J M.
(2008). Egg consumption in relation to cardiovascular disease and mortality: the Physicians' Health Study. Am. J. Clin. Nutr.
87: 964-969
[Abstract][Full Text]
Meinert, C. L
(2008). Long-term drug prevention trials. Clin Trials
5: 168-176
[Abstract]
Schaeffner, E. S., Kurth, T., Bowman, T. S., Gelber, R. P., Gaziano, J. M.
(2008). Blood pressure measures and risk of chronic kidney disease in men. Nephrol Dial Transplant
23: 1246-1251
[Abstract][Full Text]
Patrono, C., Rocca, B.
(2008). Aspirin: Promise and Resistance in the New Millennium. Arterioscler. Thromb. Vasc. Bio.
28: s25-s32
[Abstract][Full Text]
Yates, L. B., Djousse, L., Kurth, T., Buring, J. E., Gaziano, J. M.
(2008). Exceptional Longevity in Men: Modifiable Factors Associated With Survival and Function to Age 90 Years. Arch Intern Med
168: 284-290
[Abstract][Full Text]
Djousse, L., Gaziano, J. M.
(2008). Egg Consumption and Risk of Heart Failure in the Physicians' Health Study. Circulation
117: 512-516
[Abstract][Full Text]
Chavarro, J. E., Stampfer, M. J., Campos, H., Kurth, T., Willett, W. C., Ma, J.
(2008). A Prospective Study of Trans-Fatty Acid Levels in Blood and Risk of Prostate Cancer. Cancer Epidemiol. Biomarkers Prev.
17: 95-101
[Abstract][Full Text]
Barrett, K. M., Worrall, B. B.
(2007). Sex and stroke: Are they really different in midlife?. Neurology
69: 1894-1895
[Full Text]
Grodstein, F., Kang, J. H., Glynn, R. J., Cook, N. R., Gaziano, J. M.
(2007). A Randomized Trial of Beta Carotene Supplementation and Cognitive Function in Men: The Physicians' Health Study II. Arch Intern Med
167: 2184-2190
[Abstract][Full Text]
McIntyre, M. H., Kantoff, P. W., Stampfer, M. J., Mucci, L. A., Parslow, D., Li, H., Gaziano, J. M., Abe, M., Ma, J.
(2007). Prostate Cancer Risk and ESR1 TA, ESR2 CA Repeat Polymorphisms. Cancer Epidemiol. Biomarkers Prev.
16: 2233-2236
[Abstract][Full Text]
Khella, S., Bleicher, M. B.
(2007). Stroke and Its Prevention in Chronic Kidney Disease. CJASN
2: 1343-1351
[Abstract][Full Text]
Djousse, L., Gaziano, J. M.
(2007). Breakfast Cereals and Risk of Heart Failure in the Physicians' Health Study I. Arch Intern Med
167: 2080-2085
[Abstract][Full Text]
Michaud, D. S., Wolpin, B., Giovannucci, E., Liu, S., Cochrane, B., Manson, J. E., Pollak, M. N., Ma, J., Fuchs, C. S.
(2007). Prediagnostic Plasma C-Peptide and Pancreatic Cancer Risk in Men and Women. Cancer Epidemiol. Biomarkers Prev.
16: 2101-2109
[Abstract][Full Text]
Rexrode, K. M., Ridker, P. M., Hegener, H. H., Buring, J. E., Manson, J. E., Zee, R. Y.L.
(2007). Polymorphisms and Haplotypes of the Estrogen Receptor-{beta} Gene (ESR2) and Cardiovascular Disease in Men and Women. Clin. Chem.
53: 1749-1756
[Abstract][Full Text]
Wang, T. H., Bhatt, D. L., Fox, K. A.A., Steinhubl, S. R., Brennan, D. M., Hacke, W., Mak, K.-H., Pearson, T. A., Boden, W. E., Steg, P. G., Flather, M. D., Montalescot, G., Topol, E. J., on behalf of the CHARISMA Investigators,
(2007). An analysis of mortality rates with dual-antiplatelet therapy in the primary prevention population of the CHARISMA trial. Eur Heart J
28: 2200-2207
[Abstract][Full Text]
Gray, J., Mao, J. T., Szabo, E., Kelley, M., Kurie, J., Bepler, G.
(2007). Lung Cancer Chemoprevention: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition). Chest
132: 56S-68S
[Abstract][Full Text]
Wolpin, B. M., Michaud, D. S., Giovannucci, E. L., Schernhammer, E. S., Stampfer, M. J., Manson, J. E., Cochrane, B. B., Rohan, T. E., Ma, J., Pollak, M. N., Fuchs, C. S.
(2007). Circulating Insulin-Like Growth Factor Binding Protein-1 and the Risk of Pancreatic Cancer. Cancer Res.
67: 7923-7928
[Abstract][Full Text]
Nicolucci, A., De Berardis, G., Sacco, M., Tognoni, G.
(2007). AHA/ADA vs. ESC/EASD recommendations on aspirin as a primary prevention strategy in people with diabetes: how the same data generate divergent conclusions. Eur Heart J
28: 1925-1927
[Abstract][Full Text]
Rich, D. Q., Gaziano, J. M., Kurth, T.
(2007). Geographic Patterns in Overall and Specific Cardiovascular Disease Incidence in Apparently Healthy Men in the United States. Stroke
38: 2221-2227
[Abstract][Full Text]
Chavarro, J. E., Stampfer, M. J., Li, H., Campos, H., Kurth, T., Ma, J.
(2007). A Prospective Study of Polyunsaturated Fatty Acid Levels in Blood and Prostate Cancer Risk. Cancer Epidemiol. Biomarkers Prev.
16: 1364-1370
[Abstract][Full Text]
Beckley, E. T.
(2007). Women Need Tailored CHD Prevention. DOC News
4: 5-5
[Full Text]
Driver, J. A., Logroscino, G., Buring, J. E., Gaziano, J. M., Kurth, T.
(2007). A Prospective Cohort Study of Cancer Incidence Following the Diagnosis of Parkinson's Disease. Cancer Epidemiol. Biomarkers Prev.
16: 1260-1265
[Abstract][Full Text]
Kang, J. H., Cook, N., Manson, J., Buring, J. E, Grodstein, F.
(2007). Low dose aspirin and cognitive function in the women's health study cognitive cohort. BMJ
334: 987-987
[Abstract][Full Text]
Meadows, T. A., Bhatt, D. L.
(2007). Clinical Aspects of Platelet Inhibitors and Thrombus Formation. Circ. Res.
100: 1261-1275
[Abstract][Full Text]
Kurth, T., Gaziano, J. M., Cook, N. R., Bubes, V., Logroscino, G., Diener, H.-C., Buring, J. E.
(2007). Migraine and Risk of Cardiovascular Disease in Men. Arch Intern Med
167: 795-801
[Abstract][Full Text]
Ellenberg, S. S., Sun, W.
(2007). Adjuvant Therapy for Gastric Cancer: How Negative Results Can Help Patients. JNCI J Natl Cancer Inst
99: 580-582
[Full Text]
Pinsky, P., Miller, A, Kramer, B., Church, T, Reding, D, Prorok, P, Gelmann, E, Schoen, R., Buys, S, Hayes, R., Berg, C.
(2007). Evidence of a Healthy Volunteer Effect in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Am J Epidemiol
165: 874-881
[Abstract][Full Text]
Baron, J. A.
(2007). Can Aspirin Keep Mortality at Bay?. Arch Intern Med
167: 535-536
[Full Text]
Chan, A. T., Manson, J. E., Feskanich, D., Stampfer, M. J., Colditz, G. A., Fuchs, C. S.
(2007). Long-term Aspirin Use and Mortality in Women. Arch Intern Med
167: 562-572
[Abstract][Full Text]
Christen, W. G., Manson, J. E., Glynn, R. J., Gaziano, J. M., Chew, E. Y., Buring, J. E., Hennekens, C. H.
(2007). Beta Carotene Supplementation and Age-Related Maculopathy in a Randomized Trial of US Physicians. Arch Ophthalmol
125: 333-339
[Abstract][Full Text]
Hall, M. N., Campos, H., Li, H., Sesso, H. D., Stampfer, M. J., Willett, W. C., Ma, J.
(2007). Blood Levels of Long-Chain Polyunsaturated Fatty Acids, Aspirin, and the Risk of Colorectal Cancer. Cancer Epidemiol. Biomarkers Prev.
16: 314-321
[Abstract][Full Text]
Clappers, N, Brouwer, M A, Verheugt, F W A
(2007). Antiplatelet treatment for coronary heart disease. Heart
93: 258-265
[Full Text]
Samuels, M. A.
(2007). Update in Neurology. ANN INTERN MED
146: 128-132
[Full Text]
Barr, R. G., Kurth, T., Stampfer, M. J., Buring, J. E., Hennekens, C. H., Gaziano, J. M.
(2007). Aspirin and Decreased Adult-Onset Asthma: Randomized Comparisons from the Physicians' Health Study. Am. J. Respir. Crit. Care Med.
175: 120-125
[Abstract][Full Text]
Bibbins-Domingo, K., Fernandez, A.
(2007). BiDil for Heart Failure in Black Patients: Implications of the U.S. Food and Drug Administration Approval. ANN INTERN MED
146: 52-56
[Abstract][Full Text]
Djousse, L., Gaziano, J. M.
(2007). Alcohol Consumption and Risk of Heart Failure in the Physicians' Health Study I. Circulation
115: 34-39
[Abstract][Full Text]
Buse, J. B., Ginsberg, H. N., Bakris, G. L., Clark, N. G., Costa, F., Eckel, R., Fonseca, V., Gerstein, H. C., Grundy, S., Nesto, R. W., Pignone, M. P., Plutzky, J., Porte, D., Redberg, R., Stitzel, K. F., Stone, N. J.
(2007). Primary Prevention of Cardiovascular Diseases in People With Diabetes Mellitus: A Scientific Statement From the American Heart Association and the American Diabetes Association. Circulation
115: 114-126
[Abstract][Full Text]
Buse, J. B., Ginsberg, H. N., Bakris, G. L., Clark, N. G., Costa, F., Eckel, R., Fonseca, V., Gerstein, H. C., Grundy, S., Nesto, R. W., Pignone, M. P., Plutzky, J., Porte, D., Redberg, R., Stitzel, K. F., Stone, N. J.
(2007). Primary Prevention of Cardiovascular Diseases in People With Diabetes Mellitus: A scientific statement from the American Heart Association and the American Diabetes Association. Diabetes Care
30: 162-172
[Abstract][Full Text]
Sturmer, T., Buring, J. E., Lee, I-M., Gaziano, J. M., Glynn, R. J.
(2006). Metabolic Abnormalities and Risk for Colorectal Cancer in the Physicians' Health Study. Cancer Epidemiol. Biomarkers Prev.
15: 2391-2397
[Abstract][Full Text]
Okereke, O. I., Kang, J. H., Ma, J., Gaziano, J. M., Grodstein, F.
(2006). Midlife Plasma Insulin-Like Growth Factor I and Cognitive Function in Older Men. J. Clin. Endocrinol. Metab.
91: 4306-4312
[Abstract][Full Text]
Bowman, T. S., Gaziano, J. M., Kase, C. S., Sesso, H. D., Kurth, T.
(2006). Blood pressure measures and risk of total, ischemic, and hemorrhagic stroke in men.. Neurology
67: 820-823
[Abstract][Full Text]
Kurth, T.
(2006). Letter by Kurth Regarding Article, "Nonsteroidal Antiinflammatory Drugs, Acetaminophen, and the Risk of Cardiovascular Events". Circulation
114: e495-e495
[Full Text]
Bushnell, C. D., Hurn, P., Colton, C., Miller, V. M., del Zoppo, G., Elkind, M. S.V., Stern, B., Herrington, D., Ford-Lynch, G., Gorelick, P., James, A., Brown, C. M., Choi, E., Bray, P., Newby, L. K., Goldstein, L. B., Simpkins, J.
(2006). Advancing the Study of Stroke in Women: Summary and Recommendations for Future Research From an NINDS-Sponsored Multidisciplinary Working Group. Stroke
37: 2387-2399
[Abstract][Full Text]
